RUBIUS THERAPEUTICS INC's ticker is RUBY and the CUSIP is 78116T103. A total of 92 filers reported holding RUBIUS THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.25 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $138,000 | -66.9% | 162,657 | +277.2% | 0.00% | 0.0% |
| Q4 2021 | $417,000 | -2.3% | 43,117 | +146.4% | 0.00% | -50.0% |
| Q2 2021 | $427,000 | +4.1% | 17,500 | +13.1% | 0.00% | 0.0% |
| Q1 2021 | $410,000 | +151.5% | 15,475 | -27.9% | 0.00% | +100.0% |
| Q4 2020 | $163,000 | -39.4% | 21,455 | -60.1% | 0.00% | -75.0% |
| Q3 2020 | $269,000 | +52.8% | 53,710 | +82.7% | 0.00% | +33.3% |
| Q2 2020 | $176,000 | – | 29,402 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |